搜索筛选:
搜索耗时1.2968秒,为你在为你在102,285,761篇论文里面共找到 5 篇相符的论文内容
发布年度:
[期刊论文] 作者：Yan Xu,Shixuan Liu,Wenbing Xu,Jinmei Luo,Jingwen Niu,Zhi Liu,Jinming Gao,Jinglan Wang,Yi Dai,Mengzhao Wang,
来源：中国医学科学杂志（英文版） 年份：2021
Objective BAG3-related myopathy is a rare condition so far reported in twenty patients worldwide.The purpose of this study was to draw attention to this rare disease and to the fact that BAG3-related myopathy should be considered as a rare ......
Impact of crizotinib on long-term survival of ALK-positive advanced non-small-cell lung cancer: A Ch
[期刊论文] 作者：Puyuan Xing,Di Ma,Qiang Wang,Xuezhi Hao,Mengzhao Wang,Yan Wang,Li Shan,Tao Xin,Li Liang,Hongge Liang,,
来源：中国癌症研究（英文版） 年份：2019
Objective:Crizotinib has demonstrated promising efficacy in patients with anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer (NSCLC) in clinic...
[会议论文] 作者：Yi-Long Wu,Shun Lu,Ying Cheng,Caicun Zhou,Mengzhao Wang,Shukui Qin,You Lu,Yang Zhang,Yunzhong Zhu,Helen,
来源：第十六届全国临床肿瘤学大会暨2013年CSCO学术年会 年份：2013
目的: It has been demonstrated that pemetrexed/cisplatin (A/C) has superior survival benefit and better safety profile over standard first line chemotherapy with gemcitabine/cisplatin (G/C) in patients...
A multicenter, randomized, controlled trial of S-1/Cisplatin vs.Docetaxel/Cisplatin for treatment of
[会议论文] 作者：Jianhua Chang,Yuankai Shi,Jianxing He,Mengzhao Wang,Baohui Han,Xiaoqing Liu,Gongyan Chen,Caicun Zhou,,
来源：第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份：2014
Objective: Platinum based doublet chemotherapy is standard treatment for treatment na(i)ve advanced NSCLC pts, although molecularly targeted therapy can improve outcome of selected patients who harbor...
[期刊论文] 作者：,Qingyuan Zhang,Wensheng Qiu,Binghe Xu,Ruihua Xu,Bo Shen,Zhiguo Luo,Xiaodong Xie,Jianhua Chang,Mengzhao Wang,
来源：癌症生物学与医学（英文版） 年份：2020
Chemotherapy-induced neutropenia (CIN) is a potentially fatal and common complication in myelosuppressive chemotherapy. The timing and grade of CIN may play pro...
相关搜索：
